Prof. Claudia Langenberg Awarded ERC Consolidator Grant
We are proud to celebrate a major milestone for Precision Healthcare and for Queen Mary University of London. This year, four Queen Mary academics have been awarded prestigious European Research Council (ERC) Consolidator Grants, placing them among just 349 researchers selected from more than 3,000 applicants across Europe.
PHURI are delighted to recognise Professor Claudia Langenberg, our Director, who has been awarded a €2 million ERC Consolidator Grant for her ambitious project D-MAPS: Mechanisms of Multimorbidity – from Populations to Cells.
D-MAPS will, for the first time, develop a comprehensive, data-driven map of how diseases cluster through shared causes. By integrating large-scale human molecular and clinical data from diverse populations, the programme aims to uncover nodal mechanisms that influence not just one disease, but multiple conditions simultaneously. This work has the potential to transform prevention and intervention strategies and redefine how we understand complex disease.
As Professor Langenberg explains:
“The European Commission’s ERC Consolidator funding of D-MAPS supports the development of a fundamentally different scientific approach and catalyses a move from focusing on one disease at a time to studying disease and organ systems and shared causes. It is a huge privilege to be given the opportunity to lead and deliver this ambitious programme of work with my outstanding team.”
We congratulate Professor Langenberg and all Queen Mary awardees for this outstanding success.